ECHOGENIC LIPSOMES FOR TARGETED DRUG DELIVERY.
Echogenic immunoliposomes (ELIP) are under development to enable ultrasound-controlled drug delivery. Mechanistic studies in vitro have revealed that stable cavitation is correlated with enhanced recombinant tissue Plasminogen Activator (rt-PA) thrombolysis, yet strategies to optimize the occurrence of such bubble activity and avoid potential harmful bioeffects have yet to be identified. Stable cavitation is characterized by bubbles pulsating gently in response to the time-varying acoustic pressure in an ultrasound field. A review of in vitro sonothrombolysis studies utilizing commercial US contrast agent or echogenic liposomes loaded with rt-PA to nucleate stable cavitation will be presented. Strategies for the development of ultrasound-enhanced thrombolysis and drug delivery will be discussed.
Holland
Christy K
CK
Department of Biomedical Engineering, University of Cincinnati, 231 Albert Sabin Way, Medical Sciences Building, Room 6167, Cincinnati, OH, 45267-0586, USA.
McPherson
David D
DD
J Pharm Sci. 1996 May;85(5):486-90
8742939
Invest Radiol. 2002 Apr;37(4):215-21
11923644
Radiology. 1992 Nov;185(2):453-6
1410353
Am J Cardiol. 1998 Jun 18;81(12A):58G-61G
9662229
Ultrasound Med Biol. 2007 Apr;33(4):576-83
17337113
Ultrasound Med Biol. 2006 Aug;32(8):1257-67
16875959
Ultrasound Med Biol. 2008 Sep;34(9):1421-33
18378380
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2448-51
2157200
Thromb Res. 2009 Jul;124(3):306-10
19217651
J Am Soc Echocardiogr. 2000 Jun;13(6):608-14
10849515
Circulation. 1996 Dec 15;94(12):3334-40
8989148
J Control Release. 2010 Jun 15;144(3):288-95
20202474
Neuro Oncol. 2000 Jan;2(1):45-59
11302254
J Liposome Res. 2008;18(2):95-112
18569446
Thromb Res. 2008;121(5):663-73
17854867
J Mol Biol. 1965 Aug;13(1):238-52
5859039
J Drug Target. 2007 Feb;15(2):109-14
17365281
Ultrasound Med Biol. 2002 Mar;28(3):339-48
11978414
Semin Interv Cardiol. 1996 Mar;1(1):8-16
9552480
J Pharm Sci. 2001 Dec;90(12):1917-26
11745750